ICU Medical, Inc. to Present at Raymond James’ 39th Annual Institutional Investors Conference

SAN CLEMENTE, Calif., March 02, 2018 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond James’ 39th Annual Institutional Investors Conference, held on March 4-7, 2018 at the JW Marriott Orlando Grande Lakes Hotel in Orlando, Florida.

ICU Medical’s presentation will take place on Wednesday, March 7, 2018 at 10:25 AM Eastern Time.

The presentation will be webcast live and can be accessed by going to the Company's website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in vascular therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.

CONTACT:      

ICU Medical, Inc.
Scott Lamb, Chief Financial Officer
(949) 366-2183

ICR, Inc.
John Mills, Partner
(646) 277-1254